| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| POMPOMDOCTOR Ltd | 32.72M | 0.31 | -0.25 | 12.37% | -41.85% |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Sales/Revenue | 215.38M | 245.22M | 304.85M | 342.56M |
| Revenue Growth % | - | 0.14% | 0.24% | 0.12% |
| Cost of Goods Sold | 162.88M | 190.36M | 266.13M | 294.86M |
| COGS % of Revenue | 0.76% | 0.78% | 0.87% | 0.86% |
| Gross Profit | 52.51M | 54.86M | 38.72M | 47.69M |
| Gross Margin % | 0.24% | 0.22% | 0.13% | 0.14% |
| Gross Profit Growth % | - | 0.04% | -0.29% | 0.23% |
| Operating Expenses | 132.18M | 58.46M | 60.97M | 73.49M |
| OpEx % of Revenue | 0.61% | 0.24% | 0.2% | 0.21% |
| Selling, General & Admin | 102.95M | 54.87M | 55.99M | 68.24M |
| SG&A % of Revenue | 0.48% | 0.22% | 0.18% | 0.2% |
| Research & Development | 4.28M | 3.59M | 3.37M | 3M |
| R&D % of Revenue | 0.02% | 0.01% | 0.01% | 0.01% |
| Other Operating Expenses | 24.94M | 0 | 1.61M | 2.24M |
| Operating Income | -79.67M | -3.59M | -22.25M | -25.79M |
| Operating Margin % | -0.37% | -0.01% | -0.07% | -0.08% |
| Operating Income Growth % | - | 0.95% | -5.19% | -0.16% |
| EBITDA | -58.35M | -3.81M | -22.14M | -25.66M |
| EBITDA Margin % | -0.27% | -0.02% | -0.07% | -0.07% |
| EBITDA Growth % | - | 0.93% | -4.81% | -0.16% |
| D&A (Non-Cash Add-back) | 21.32M | 0 | 112.09K | 134.51K |
| EBIT | -79.89M | -3.81M | -23.1M | -24.4M |
| Net Interest Income | -16.29M | -16.02M | -13.85M | -12.96M |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 16.29M | 16.02M | 13.85M | 12.96M |
| Other Income/Expense | -16.51M | -16.24M | -14.7M | -11.57M |
| Pretax Income | -96.18M | -19.83M | -36.95M | -37.37M |
| Pretax Margin % | -0.45% | -0.08% | -0.12% | -0.11% |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1.96% | 6.33% | 3.93% | 3.84% |
| Net Income | -188.4M | -125.51M | -145.39M | -143.36M |
| Net Margin % | -0.87% | -0.51% | -0.48% | -0.42% |
| Net Income Growth % | - | 0.33% | -0.16% | 0.01% |
| Net Income (Continuing) | -96.18M | -19.83M | -36.95M | -37.37M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 71.66M | 76.66M | 158.64M | 168.69M |
| EPS (Diluted) | -1.59 | -1.06 | -1.23 | -1.21 |
| EPS Growth % | - | 0.33% | -0.16% | 0.02% |
| EPS (Basic) | -1.59 | -1.06 | -1.23 | -1.21 |
| Diluted Shares Outstanding | 118.44M | 118.44M | 118.44M | 118.44M |
| Basic Shares Outstanding | 118.44M | 118.44M | 118.44M | 118.44M |
| Dividend Payout Ratio | - | - | - | - |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Total Current Assets | 18.43M | 47.74M | 59.42M | 37.5M |
| Cash & Short-Term Investments | 2.17M | 2.49M | 6.72M | 7.65M |
| Cash Only | 2.17M | 2.49M | 6.72M | 7.65M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 739.57K | 27.25M | 32.39M | 14.97M |
| Days Sales Outstanding | 1.25 | 40.57 | 38.78 | 15.95 |
| Inventory | 8.12M | 8.2M | 12.69M | 9.17M |
| Days Inventory Outstanding | 18.19 | 15.71 | 17.41 | 11.35 |
| Other Current Assets | 0 | 159.9K | 88.07K | 0 |
| Total Non-Current Assets | 877.63K | 877.63K | 6.89M | 8.73M |
| Property, Plant & Equipment | 0 | 0 | 595.87K | 461.36K |
| Fixed Asset Turnover | - | - | 511.61x | 742.49x |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Long-Term Investments | 500K | 500K | 0 | 0 |
| Other Non-Current Assets | 377.63K | 377.63K | 6.29M | 8.27M |
| Total Assets | 19.31M | 48.62M | 66.31M | 46.23M |
| Asset Turnover | 11.15x | 5.04x | 4.60x | 7.41x |
| Asset Growth % | - | 1.52% | 0.36% | -0.3% |
| Total Current Liabilities | 109.39M | 143.61M | 172M | 179.15M |
| Accounts Payable | 30.41M | 43.35M | 41.69M | 25.35M |
| Days Payables Outstanding | 68.14 | 83.12 | 57.18 | 31.38 |
| Short-Term Debt | 23.38M | 29.45M | 55.41M | 72.95M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 0 | 0 | 0 | 2.08M |
| Current Ratio | 0.17x | 0.33x | 0.35x | 0.21x |
| Quick Ratio | 0.09x | 0.28x | 0.27x | 0.16x |
| Cash Conversion Cycle | -48.69 | -26.84 | -0.99 | -4.07 |
| Total Non-Current Liabilities | 1.69B | 1.8B | 1.86B | 1.96B |
| Long-Term Debt | 312.51M | 318.93M | 355.4M | 365.09M |
| Capital Lease Obligations | 2.94M | 11.44M | 1.22M | 1.67M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.37B | 1.47B | 1.5B | 1.6B |
| Total Liabilities | 1.8B | 1.95B | 2.03B | 2.14B |
| Total Debt | 341.26M | 361.24M | 413.29M | 441.1M |
| Net Debt | 339.09M | 358.76M | 406.58M | 433.45M |
| Debt / Equity | - | - | - | - |
| Debt / EBITDA | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - |
| Interest Coverage | -4.89x | -0.22x | -1.61x | -1.99x |
| Total Equity | -1.78B | -1.9B | -1.96B | -2.09B |
| Equity Growth % | - | -0.07% | -0.03% | -0.07% |
| Book Value per Share | -15.01 | -16.02 | -16.56 | -17.69 |
| Total Shareholders' Equity | -1.85B | -1.97B | -2.12B | -2.26B |
| Common Stock | 2.79K | 2.79K | 4.4K | 4.4K |
| Retained Earnings | -1.85B | -1.97B | -2.12B | -2.26B |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | -5.23K |
| Minority Interest | 71.66M | 76.66M | 158.64M | 168.69M |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Cash from Operations | -15.68M | -22.02M | -45.8M | -16.13M |
| Operating CF Margin % | -0.07% | -0.09% | -0.15% | -0.05% |
| Operating CF Growth % | - | -0.4% | -1.08% | 0.65% |
| Net Income | -96.18M | -19.83M | -36.95M | -37.37M |
| Depreciation & Amortization | 21.32M | 0 | 112.09K | 134.51K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 24.05M | -774.45K | 3.6M | 3.57M |
| Working Capital Changes | 35.14M | -1.41M | -12.56M | 17.53M |
| Change in Receivables | -917.34K | -26.75M | -4.45M | 16.45M |
| Change in Inventory | -1.59M | -77.56K | -5M | 3.03M |
| Change in Payables | 5.43M | 12.94M | -1.66M | -16.34M |
| Cash from Investing | -500K | 0 | -111.89K | -33.37K |
| Capital Expenditures | 0 | 0 | -111.89K | -37.77K |
| CapEx % of Revenue | - | - | 0% | 0% |
| Acquisitions | - | - | - | - |
| Investments | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 4.4K |
| Cash from Financing | 5.44M | 22.49M | 50.07M | 17.02M |
| Debt Issued (Net) | - | - | - | - |
| Equity Issued (Net) | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - |
| Other Financing | 0 | 0 | -2.28M | 0 |
| Net Change in Cash | - | - | - | - |
| Free Cash Flow | -15.68M | -22.02M | -45.91M | -16.17M |
| FCF Margin % | -0.07% | -0.09% | -0.15% | -0.05% |
| FCF Growth % | - | -0.4% | -1.09% | 0.65% |
| FCF per Share | -0.13 | -0.19 | -0.39 | -0.14 |
| FCF Conversion (FCF/Net Income) | 0.08x | 0.18x | 0.31x | 0.11x |
| Interest Paid | 4.05M | 3.24M | 2.39M | 2.74M |
| Taxes Paid | 0 | 0 | 0 | 0 |
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Gross Margin | 24.38% | 22.37% | 12.7% | 13.92% |
| Net Margin | -87.47% | -51.18% | -47.69% | -41.85% |
| Interest Coverage | -4.89x | -0.22x | -1.61x | -1.99x |
| FCF Conversion | 0.08x | 0.18x | 0.31x | 0.11x |
| Revenue Growth | - | 13.85% | 24.32% | 12.37% |
POMDOCTOR Ltd (POM) reported $342.6M in revenue for fiscal year 2024. This represents a 59% increase from $215.4M in 2021.
POMDOCTOR Ltd (POM) grew revenue by 12.4% over the past year. This is steady growth.
POMDOCTOR Ltd (POM) reported a net loss of $143.4M for fiscal year 2024.
POMDOCTOR Ltd (POM) had negative free cash flow of $16.2M in fiscal year 2024, likely due to heavy capital investments.